Literature DB >> 25300422

Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement.

Hoon Choi1, Jae Heon Kim, Ji Sung Shim, Jae Young Park, Seok Ho Kang, Du Geon Moon, Jun Cheon, Jeong Gu Lee, Je Jong Kim, Jae-Hyun Bae.   

Abstract

OBJECTIVE: To identify the prognostic factors causing persistent storage symptoms following transurethral resection of the prostate in patients with benign prostatic enlargement (BPE).
METHODS: A total of 116 men with symptomatic BPE requiring surgery were enrolled in the study between January 2011 and December 2012. The patients underwent basic clinical evaluations including transrectal ultrasound, International Prostate Symptom Score and urodynamic study. After 6 months, International Prostate Symptom Score and uroflowmetry were rechecked. The definition of persistent storage symptoms was patients with storage scores >7 points. Logistic regression analysis and receiver operating characteristic analysis were conducted.
RESULTS: The 116 patients were divided into a persistent storage symptom-positive group (n = 33) and a storage symptom-negative group (n = 83). Multivariate analysis showed that the degrees of worse initial storage symptoms (odds ratio [OR] = 8.32), small bladder capacity (OR = 4.31), impaired detrusor contractility (OR = 2.96) and age (OR = 1.05) were consistently associated with persistent storage symptoms.
CONCLUSIONS: This short-term study confirms the positive and consistent correlations between the baseline degree of worse initial storage symptoms, bladder capacity, detrusor contractility and age and the improvement in storage symptoms.

Entities:  

Mesh:

Year:  2014        PMID: 25300422     DOI: 10.1159/000357626

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

Review 1.  Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.

Authors:  Soo Jeong Kim; Omar Al Hussein Alawamlh; Bilal Chughtai; Richard K Lee
Journal:  Curr Urol Rep       Date:  2018-08-20       Impact factor: 3.092

2.  The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients.

Authors:  Ye Tian; Heng Zhang; Ying Cao; Lu Yang; Guangheng Luo
Journal:  Clin Interv Aging       Date:  2022-05-23       Impact factor: 3.829

3.  Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study.

Authors:  Sascha A Ahyai; Irina Marik; Tim A Ludwig; Andreas Becker; Saman Asdjodi; Luis Kluth; Felix Chun; Margit Fisch; Marianne Schmid
Journal:  World J Urol       Date:  2020-02-21       Impact factor: 4.226

4.  Risk Factors for Prostate Volume Progression After Prostate-Transurethral Resection.

Authors:  Gede Wirya Kusuma Duarsa; Daniel Oktavianus Dau; Ida Bagus Putra Pramana; Pande Made Wisnu Tirtayasa; I Wayan Yudiana; Kadek Budi Santosa; Anak Agung Gde Oka; Tjokorda Gde Bagus Mahadewa; Christopher Ryalino
Journal:  Res Rep Urol       Date:  2020-05-05

5.  The relation between the storage symptoms before and after transurethral resection of the prostate, analysis of the risk factors and the prevention of the symptoms with solifenacin.

Authors:  Timucin Sipal; Hakan Akdere
Journal:  Int Braz J Urol       Date:  2020 Jul-Aug       Impact factor: 1.541

6.  Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies.

Authors:  Dean Elterman; Peter Gilling; Claus Roehrborn; Neil Barber; Vincent Misrai; Kevin C Zorn; Naeem Bhojani; Alexis Te; Mitch Humphreys; Steven Kaplan; Mihir Desai; Thorsten Bach
Journal:  BMJ Surg Interv Health Technol       Date:  2021-06-23

Review 7.  De Novo Detrusor Underactivity and Other Urodynamic Findings after Radical Prostatectomy: A Systematic Review.

Authors:  Maciej Oszczudłowski; Konrad Bilski; Mieszko Kozikowski; Jakub Dobruch
Journal:  Medicina (Kaunas)       Date:  2022-03-04       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.